news

On March 7, 2025, led by Wang Jianrong, Chairman and Party Branch Secretary of China Health Association, Zhou Bangyong, Vice Chairman of China Health Association, Li Ping, Vice Chairman of China Health Association, Wang Zhong, Vice Chairman of China Health Association, Gao Feng, former Director of Food Evaluation Center of State Administration for Market Regulation, and other leaders visited Taiai Peptide Group to hold a research seminar on the development and implementation of the company’s party building work. Group Chairman Ms. Wu Xia, Executive Vice President Chen Ye, Chairman Assistant, Customer Service Director Han Xiaolan, and directors of various sales departments accompanied the investigation throughout the process.

Wang Jianrong, Chairman of the China Health Association and Secretary of the Party Branch, and his delegation first visited the Taiaipeptide Group’s Biotechnology Exhibition Hall. Chen Ying, Dean of the Group’s Business School, explained the exhibition hall to the leaders. At the same time, they learned in detail about the Taiaipeptide Group’s development history, main business, innovative initiatives, corporate culture and future development plans.

Ms. Wu Xia, Chairman of Tai’ai Peptide Group, welcomed the arrival of Wang Jianrong and his party, and expressed her gratitude to the China Health Association for its concern and love for Tai’ai Peptide. Starting from the actual situation of the group, Ms. Wu Xia elaborated on the legal operation, quality emphasis, strengthening research and development, innovation, and social welfare, and reported in detail to the leaders of the China Health Association research team on the implementation of the group’s work in 2024 and the plan for 2025.

Afterwards, Zhao Bin, director of the group’s brand operation center, introduced the company’s party building progress. Then, Chen Ying, dean of the group’s business school, explained the scientific knowledge of peptides, the development of peptides at home and abroad, and other related content.

During the interactive session, Chen Ye, the group’s executive vice president, asked questions based on the current situation, the group’s development, and issues encountered in the operation of the Peptide and Health Industry Branch.

Finally, Chairman Wang Jianrong made a concluding speech. He said that the selection of Taiai Peptide Group as the first stop of this survey activity fully demonstrated the company’s position in the industry. The association will promote enterprises to expand investment, increase employment, and boost consumption as the focus of learning and implementing the spirit of this year’s “Two Sessions”. He hopes that Taiai Peptide Group will play a leading role in the industry and make greater contributions to economic and social development.

This survey not only provides support for the development of Taiai Peptide Group, but also lays a solid foundation for the in-depth cooperation between the two. As a standing director unit of the China Health Association, Taiai Peptide Group will continue to uphold the concept of high-quality development, accelerate the construction of the peptide industry, and use the two platforms of the China Health Association and the Peptide and Health Industry Branch to strengthen communication and cooperation and promote the development of the big health industry.